Head and Neck Cancer
1,581
226
312
796
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
247 trials with published results (16%)
Research Maturity
796 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.5%
166 terminated out of 1581 trials
82.7%
-3.8% vs benchmark
8%
128 trials in Phase 3/4
31%
247 of 796 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 796 completed trials
Clinical Trials (1581)
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
Comparing Two Ways to Manage Head and Neck Lymphedema
A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
Effect of Exercise in Head and Neck Cancer Patients
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Evaluation of On-Couch CBCT Image Quality
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study
COPD Care Pathway Among Patients With Cancer
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
DESTINY-PANTUMOUR04